FeaturesSignalPricingFounders
Log inGet started free
AV

ARCH Venture Partners

Venture CapitalActive

ARCH is an early-stage venture firm focused on life science discoveries to prevent, detect and cure disease.

Chicago, United StatesFounded 1995archventure.com
340
Investments
72
Exits
$4.7B
AUM
21.2%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for ARCH Venture Partners.

Get started free

Investment Thesis & Strategy

ARCH Venture Partners invests in early-stage life science companies, specifically those focused on preventing, detecting, and curing diseases, across various stages of development.

Investment Activity

Deals per year over the last 7 years

1
2014
1
2015
1
2016
2
2017
4
2018
2
2019
1
2020

Portfolio Companies

Selected investments from their portfolio of 340 companies

G
Generate Biomedicines
Biotech · Series A, 2020
Active
V
Verve Therapeutics
Biotech · Series A, 2019
Active
I
Insitro
Biotech · Series B, 2019
Active
C
Cerevel Therapeutics
Biotech · Series A, 2018
Active
S
Sana Biotechnology
Biotech · Series A, 2018
Active
L
Lyell Immunopharma
Biotech · Series A, 2018
Active
B
Beam Therapeutics
Biotech · Series A, 2018
Active
V
Vir Biotechnology
Biotech · Series A, 2017
Active
G
Gossamer Bio
Biotech · Series A, 2017
Active
G
GRAIL
Biotech · Series B, 2016
Active
D
Denali Therapeutics
Biotech · Series A, 2015
Active
A
Aledade
Healthcare · Series A, 2014
Active

Frequently Asked Questions

ARCH Venture Partners focuses on Series A, Series B, Series C+ stage investments.

Related Investors

Pritzker Group Venture Capital

Chicago, United States · 210 deals

Lightbank

Chicago, United States · 150 deals

Chicago Ventures

Chicago, United States · 135 deals

Hyde Park Venture Partners

Chicago, United States · 131 deals

Second Century Ventures

Chicago, United States · 128 deals

OCA Ventures

Chicago, United States · 123 deals